Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5 |
||
Catheter ablation of the mitral isthmus line using the novel DiamondTemp Ablation system: First experience using two different ablation protocols | ||
L. Rottner1, R. Schleberger2, M. Lemoine2, I. My3, F. Moser1, J. Moser2, L. Dinshaw2, P. Kirchhof1, F. Ouyang1, B. Reißmann1, A. Metzner2, A. Rillig2 | ||
1Klinik für Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 2Klinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 3Klinik für Kardiologie, Universitäres Herz- und Gefäßzentrum UKE Hamburg GmbH, Hamburg; | ||
Background: Mitral ishmus ablation is an established approach to treat perimitral reentrant tachycardia, and is often performed as substrat modification in patients with persistent atrial fibrillation (AF). Bidirectional block of the mitral isthmus line (MIL) is still a great challenge using conventional ablation catheters, but is essential to prevent recurrence of atrial arrhythmia. Recently, the novel DiamondTempTM (DT) ablation system (Medtronic®, Inc., Minneapolis, Minnesota) was introduced and allows for high-power, short-duration ablation in a temperature-controlled mode. Its use during pulmonary vein isolation (PVI) using a recommended ablation setting with a catheter-tip temperature limit of 60°C, a temperature-controlled power of 50 W and an application duration of 10 sec has shown to be effective and safe. However, data on DT ablation settings for substrate modification, i.e., creation of linear lesions are lacking.
|
||
https://dgk.org/kongress_programme/jt2022/aP835.html |